logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5926.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5926.produseast1
Safe abortion care at MSF | Collections | MSF Science Portal
Safe abortion care at MSF

Safe abortion care at MSF

Unsafe abortion is a major cause of maternal death, and the only one that is completely preventable. Yet over 30 million unsafe abortions occur each year, leading to at least 29,000 deaths and millions of serious complications—nearly all in low- and middle-income countries. MSF teams see these tragic consequences first-hand, treating thousands of patients every year with severe, potentially life-threatening effects from unsafe abortion.


To mark International Safe Abortion Awareness Day (28 September 2024), this Collection presents highlights of MSF’s work on safe abortion care (SAC) as a way to reduce maternal death and injury. By re-assessing and reshaping how our projects deliver SAC in fragile and conflict-affected settings, we have been able to significantly expand services in those contexts and across MSF projects globally. In parallel, we also conducted in-depth studies of abortion complications and their contributing factors in fragile settings, where a dearth of evidence limits understanding of women's needs in accessing comprehensive care. These findings are helping to identify gaps in service delivery and inform operational decision-making.

Collection Content

Download Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.

  • All Assets (11)
  • CSV
  • BibTeX
  • EndNote
Download Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.

  • All Assets (11)
  • CSV
  • BibTeX
  • EndNote

See more collections

Combatting antibiotic resistance 2022

Combatting antibiotic resistance 2022
Resistance to antibiotics is a growing public health crisis, especially in countries with fragile health systems and in regions at war. The World Health Organization has estimated that antibiotic-resistant bacteria caused nearly 1.3 million deaths in 2019, a toll that will increase significantly in the coming years if effective action is not taken. To mark World Antimicrobial Awareness Week 2022 (18-24 November) we present a snapshot of MSF’s recent work on responding to this growing threat. Since many humanitarian settings lack laboratory capacity to diagnose these infections, MSF and partners have developed two new technologies with the potential to dramatically expand the availability of accurate diagnosis—allowing clinicians to then tailor antibiotic treatment accordingly. Other work from diverse contexts describes practices and challenges related to optimizing rational antibiotic use within health facilities and communities. Lastly, several studies characterize the patterns and prevalence of antibiotic resistance among MSF patients, from hospitalized neonates in Central African Republic to acute trauma patients in Haiti and Yemen.
TB-PRACTECAL Trial—Evidence for a shorter, safer, more effective treatment for drug-resistant tuberculosis

TB-PRACTECAL Trial—Evidence for a shorter, safer, more effect...
New tools and approaches to drug-resistant TB

New tools and approaches to drug-resistant TB
View All Collections
Drug-resistant tuberculosis (DR-TB) remains an especially deadly form of the ancient scourge of TB, while current treatments are long, toxic, and ineffective for half of all patients. Aiming to change this unacceptable status quo, in the mid-2010’s MSF and partners launched three clinical trials to test novel regimens containing the first new TB drugs in decades. On 22 December 2022 the New England Journal of Medicine published findings from TB-PRACTECAL, a three-country randomized controlled trial, showing that a shorter regimen is safer and cured 89% of DR-TB patients, compared with 52% on the standard of care. These findings have already been incorporated into the World Health Organization’s new TB treatment guidelines. A separate study shows that the new regimen is also more cost-effective. Alongside these results the content collection linked below highlights other aspects of the trial, from community engagement strategies that helped shape TB-PRACTECAL to setbacks arising from the Covid-19 pandemic. It also examines urgent challenges in scaling up access to these life-saving drugs, including affordability and patent barriers.
The World Health Organization estimates that 410,000 people developed a drug-resistant tuberculosis infection (DR-TB) in 2022, only 40% of whom were diagnosed and started on treatment—and only 63% then cured. Given all these points of failure, innovation in preventing, diagnosing and treating DR-TB cannot come fast enough. To mark World TB Day (24 March 2024) the content collection linked below highlights recent work by MSF and collaborators to help change this grim picture. The TB-PRACTECAL and endTB studies delivered robust evidence for shorter, safer, more effective drug regimens that are already saving lives worldwide. Other studies explore new approaches to preventive treatment and simpler, quicker, accurate detection of TB and drug resistance—especially among difficult-to-diagnose populations such as children and people living with HIV. But to impact DR-TB globally these innovations must become widely accessible. This requires changes on many fronts, as described in an accompanying Collection (Expanding Access to Lifesaving New TB Tools).
Journal Article
|
Research

Self-managed abortion as a humanitarian revolution: Accounts of a telehealth pilot in the Middle East

Lasserre L, Staderini N, Hasan M, Rossi V
2025-02-11 • Conflict and Health
2025-02-11 • Conflict and Health

BACKGROUND

Access to safe abortion care (SAC) should be improved in fragile and humanitarian settings, and the implementation of interventions in that regard ar...

Journal Article
|
Research

Assessing post-abortion care using the WHO quality of care framework for maternal and newborn health: a cross-sectional study in two African hospitals in humanitarian settings

Pasquier E, Owolabi OO, Powell B, Fetters T, Ngbale R,  et al.
2024-08-05 • Reproductive Health
2024-08-05 • Reproductive Health

BACKGROUND

Abortion-related complications remain a main cause of maternal mortality. There is little evidence on the availability and quality of post-abortion c...

Journal Article
|
Research

Reasons for delay in reaching healthcare with severe abortion-related morbidities: Qualitative results from women in the fragile context of Jigawa state, Nigeria (AMoCo)

Moore AM, Fetters T, Williams T, Pasquier E, Kantiok J,  et al.
2023-12-01 • SSM - Qualitative Research in Health
2023-12-01 • SSM - Qualitative Research in Health
Maternal near-miss events are a key measure of maternal health; abortion-related complications are one source of near-miss events. To understand the pathway to care of women with severe ...
Technical Report
|
Evidence Brief

The magnitude and severity of abortion-related complications: Referral Hospital in Jigawa State, a fragile setting - Results of the AMoCo study

Fotheringham C, Moore AM, Owolabi OO, Fetters T, Chen H,  et al.
2023-08-01
2023-08-01

A dearth of evidence on abortion complications in fragile settings limits the understanding of women’s needs in access to comprehensive abortion care in contexts like Jigawa state. Th...

Journal Article
|
Pre-Print

Lessons learned conducting abortion research in fragile contexts: Reflections from a mixed methods study in Africa (the AMoCo study)

Moore AM, Pasquier E, Williams TN, Fetters T, Powell B,  et al.
2023-03-20 • Research Square
2023-03-20 • Research Square
BACKGROUND
Conducting abortion research in fragile settings presents challenges, many of which are present in other low-resourced settings to various degrees but when appearing all t...
Journal Article
|
Research

High severity of abortion complications in fragile and conflict-affected settings: a cross-sectional study in two referral hospitals in sub-Saharan Africa (AMoCo study)

Pasquier E, Owolabi OO, Fetters T, Ngbale RN, Adame Gbanzi MC,  et al.
2023-03-04 • BMC Pregnancy and Childbirth
2023-03-04 • BMC Pregnancy and Childbirth
BACKGROUND
Abortion-related complications are one of the five main causes of maternal mortality. However, research about abortion is very limited in fragile and conflict-affected set...
Journal Article
|
Research

Catalyst for change: Lessons learned from overcoming barriers to providing safe abortion care in Médecins Sans Frontières projects

Kumar M, Schulte-Hillen C, De Plecker E, Van Haver A, Marques SG,  et al.
2022-10-23 • Perspectives on Sexual and Reproductive Health
2022-10-23 • Perspectives on Sexual and Reproductive Health
CONTEXT
Despite instituting a policy in 2004, Médecins Sans Frontières (MSF) continuously struggled to routinely provide safe abortion care (SAC). In 2016, the organization launched ...
Conference Material
|
Poster

Provision of safe abortion care: a multicentre descriptive mixed-methods analysis, MSF OCB 2018-2020

Van Haver A, Lagrou D, Van der Bergh R, Lynen M, Vaquero M,  et al.
2021-05-18 • MSF Scientific Days International 2021: Research
2021-05-18 • MSF Scientific Days International 2021: Research
Journal Article
|
Commentary

Now is the time: a call for increased access to contraception and safe abortion care during the COVID-19 pandemic

Kumar M, Daly M, de Plecker E, Jamet C, McRae M,  et al.
2020-07-20 • BMJ Global Health
2020-07-20 • BMJ Global Health
SUMMARY BOX

• The COVID-19 pandemic has begun to severely limit access to sexual and reproductive healthcare, including contraception and safe abortion care (SAC), which have h...
Conference Material
|
Video

Overcoming barriers to provision of safe abortion care in MSF projects: Task Force approach

Kumar M
2019-05-10 • MSF Scientific Days International 2019
2019-05-10 • MSF Scientific Days International 2019
Journal Article
|
Letter

Why Médecins Sans Frontières (MSF) provides safe abortion care and what that involves

Schulte-Hillen C, Staderini N, Saint-Sauveur JF
2016-09-21 • Conflict and Health
2016-09-21 • Conflict and Health
MSF responds to needs for the termination of pregnancy, including on request (TPR); it is part of the organization's work aimed at reducing maternal mortality and suffering; and preventi...